The Hidden Dimension of Façades: Fractal Analysis Reveals Composition Rules in Classical and Renaissance Architecture
Fractal and Fractional · 11.03.2023 · 7 (3) · 257
DOI: 10.3390/fractalfract7030257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fractal and Fractional, online erschienen am 11.03.2023. Verfasst von Vilmos Katona. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study uses fractal analysis to measure the detailed intensity of well-known Classical and Renaissance façades. The study develops a method to understand their interrelated design principles more comprehensively. With this evaluation tool, one can observe intrinsic connections that support the historical continuity and point out balancing composition protocols, such as the ‘compensation rule’, that regulated design for centuries. The calculations offer mathematical constants to identify Classical and Renaissance details by plasticity rates. Finally, we base this method on spatial evaluation. Our calculations involve depth, which connects planar front views with the haptic reality of the façades’ tectonic layers. The article also discusses the cultural and urban implications of our results.
Zitieren
APA
Katona, V. (2023). The Hidden Dimension of Façades: Fractal Analysis Reveals Composition Rules in Classical and Renaissance Architecture. Fractal and Fractional, 7(3), 257. https://doi.org/10.3390/fractalfract7030257
Vancouver
Katona V. The Hidden Dimension of Façades: Fractal Analysis Reveals Composition Rules in Classical and Renaissance Architecture. Fractal and Fractional. 2023;7(3):257. doi:10.3390/fractalfract7030257
BibTeX
@article{Katona2023,
author = {Katona, Vilmos},
title = {The Hidden Dimension of Façades: Fractal Analysis Reveals Composition Rules in Classical and Renaissance Architecture},
journal = {Fractal and Fractional},
year = {2023},
volume = {7},
number = {3},
pages = {257},
doi = {10.3390/fractalfract7030257}
}
EUVIMED